|
Selleck Chemicals
bemcentinib ![]() Bemcentinib, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/axl+bemcentinib/Bemcentinib/pmc11000354-93-0-10 Average 94 stars, based on 1 article reviews
bemcentinib - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
axl kinase inhibitor r428 ![]() Axl Kinase Inhibitor R428, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/axl+bemcentinib/Bemcentinib/pmc07015993__mmc1-147-0-7 Average 96 stars, based on 1 article reviews
axl kinase inhibitor r428 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
BerGenBio
bemcentinib axl ![]() Bemcentinib Axl, supplied by BerGenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/axl+bemcentinib/bgb324/pmc09305809-5-0-3 Average 90 stars, based on 1 article reviews
bemcentinib axl - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
BerGenBio
axl inhibitor bemcentinib r428 ![]() Axl Inhibitor Bemcentinib R428, supplied by BerGenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/axl+bemcentinib/r428/pmc12205699-691-3-17 Average 90 stars, based on 1 article reviews
axl inhibitor bemcentinib r428 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
TargetMol
axl inhibitor bemcentinib ![]() Axl Inhibitor Bemcentinib, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/axl+bemcentinib/Cytokine+Inhibitor+Library/pm42260511-199-10-13 Average 95 stars, based on 1 article reviews
axl inhibitor bemcentinib - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
BerGenBio
axl inhibitor bemcentinib ![]() Axl Inhibitor Bemcentinib, supplied by BerGenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/axl+bemcentinib/axl+kinase+inhibitor/pm33586501-139-71-70 Average 90 stars, based on 1 article reviews
axl inhibitor bemcentinib - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Fluids and Barriers of the CNS
Article Title: SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway
doi: 10.1186/s12987-024-00533-9
Figure Lengend Snippet: Medium components used in the BBB studies
Article Snippet:
Techniques: Concentration Assay, Solvent
Journal: Fluids and Barriers of the CNS
Article Title: SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway
doi: 10.1186/s12987-024-00533-9
Figure Lengend Snippet: SARS-CoV-2 receptor for infection examined in human iPSC-BMELCs. A Expression of SARS-CoV-2 receptor candidates was determined by RT-qPCR. B Cells were treated with ACE2 Ab (20 μg/mL), Meplazumab (20 μg/mL), Bemcentinib (1 μM), or EG00229 (100 μM) 1 h before SARS-CoV-2 infection (MOI = 1). The intracellular viral copy number was determined by RT-qPCR. Normalized value of SARS-CoV-2 RNA copies was indicated against vehicle control as 100%. Data are represented as mean ± SD (n = 3)
Article Snippet:
Techniques: Infection, Expressing, Quantitative RT-PCR, Control
Journal: Journal for Immunotherapy of Cancer
Article Title: Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects
doi: 10.1136/jitc-2022-004863
Figure Lengend Snippet: Selected studies of TAM receptor inhibitors combined with CPI therapies in CPI-resistant NSCLC
Article Snippet:
Techniques: